Jazz Pharmaceuticals plc (JAZZ): Shareholders' Equity
$4.32B
As of 2025-12-31
$4.80B
As of 2026-06-30
+11.9%
3-year compound annual growth
+3.4%
5-year compound annual growth
+10.4%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.32B | +5.5% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $4.09B | +9.5% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $3.74B | +21.1% | 2026-02-24, Balance as of period end |
| 2022-12-31 | $3.09B | -22.2% | 2025-02-26, Balance as of period end |
| 2021-12-31 | $3.97B | +8.3% | 2024-02-28, Balance as of period end |
| 2020-12-31 | $3.66B | +17.6% | 2023-03-01, Balance as of period end |
| 2019-12-31 | $3.11B | +12.8% | 2022-03-01, Balance as of period end |
| 2018-12-31 | $2.76B | +1.6% | 2021-02-23, Balance as of period end |
| 2017-12-31 | $2.71B | +44.5% | 2020-02-25, Balance as of period end |
| 2016-12-31 | $1.88B | +17.4% | 2018-02-27, Balance as of period end |
| 2015-12-31 | $1.60B | +16.6% | 2016-02-23, Balance as of period end |
| 2014-12-31 | $1.37B | +5.8% | 2016-02-23, Balance as of period end |
| 2013-12-31 | $1.30B | +15.5% | 2015-02-24, Balance as of period end |
| 2012-12-31 | $1.12B | +481.6% | 2014-02-25, Balance as of period end |
| 2011-12-31 | $192.79M | +531.0% | 2014-02-25, Balance as of period end |
| 2010-12-31 | $30.55M | n/m | 2013-02-26, Balance as of period end |
| 2009-12-31 | -$72.83M | n/a | 2012-02-28, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $4.32B | +5.5% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $2.94B | -32.0% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $6.55B | +7.4% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $789.18M | n/m |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $4.36B | +30.9% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $6.09B | +7.6% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $7.10B | +10.1% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | -$70.79M | n/m |
| Organon & Co. (OGN) | 2025-12-31 | $752.00M | +59.3% |
Compare JAZZ, PRGO, ELAN, ALNY side by side · Screen every company in Pharmaceutical Preparations ↗